New patents in Taiwan's infant biotechnology industry hit a brick wall when they reach the government's regulatory body, as there aren't enough examiners to cope with the workload, experts said yesterday.
"The speed of the review process is quite slow as there are very few biotechnology reviewers at the Intellectual Property Office [IPO]," said Liang Chi-ming (
Liang was speaking on the second and final day of a Taiwan-Europe government-level joint seminar on intellectual property rights (IPR) protection and enforcement in Taipei yesterday.
Taiwan currently has 150 patent examiners, according to statistics from the IPO, which is under the Ministry of Economic Affairs. The vast majority work on information technology innovations, such as computer chip circuit design.
Reviewers dedicated to biotechnology and medicine number as few as 20. Another 50 examiners are being recruited this year, but only two will be assigned to biotech, sources at the IPO said yesterday without giving their names.
Biotech companies are feeling the pinch.
"The IPO does not have enough examiners with a biotechnology background," Ben Liang (
"They often have to outsource the work to universities which have the technical knowledge, but don't have the professional patent knowledge, so cases are passed back and forth. It takes us three to five years to get a patent," Liang said.
But Taiwan may not be unique in having a backlog of biotech patents pending.
"Biotech is a new field and the patent process takes a long time as not enough people have the relevant background or knowledge," Liang said.
"It also takes two to three years to get a patent in the US, and even up to 10 years in a controversial case," he said.
The US Patent and Trademark Office is also trying to simplify the patent application procedure for biotech inventions.
The office intends to limit the number of inventions claimed in one application to speed up the process, according to a statement on its Web site dated Monday.
Taiwan is now addressing the problem.
"There are currently very few biotech patent reviewers, but next year we will have a new system for utilizing patent number registration that could save manpower in this field," Hsieh Ming-yang (
From 1976 until the end of last year, the IPO granted almost 20,000 patents in the field of biotechnology and related areas, its statistics show.
Of those, 56 were for Chinese herbs, 8,019 for biotechnology innovations and 10,669 for medicines.
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has approved a capital budget of US$31.28 billion for production expansion to meet long-term development needs during the artificial intelligence (AI) boom. The company’s board meeting yesterday approved the capital appropriation plan for purposes such as the installation of advanced technology capacity and fab construction, the world’s largest contract chipmaker said in a statement. At an earnings conference last month, TSMC forecast that its capital expenditure for this year would be at the higher end of the US$52 billion to US$56 billion range it forecast in January in response to robust demand for 5G, AI and
NEW MARKET: The partnership opens up India to the Dutch company, which already has a strong hold in the semiconductor market of South Korea, Taiwan and China ASML Holding NV entered into a partnership agreement with Tata Electronics Pvt Ltd aimed at ramping up India’s goal to develop domestic chip-manufacturing capabilities. The Dutch company’s technology would help power Tata Electronics’ planned 300 millimeter (mm) semiconductor foundry in Gujarat, according to a joint statement from the two companies on Saturday. The signing of a memorandum of understanding coincides with a visit by Indian Prime Minister Narendra Modi to the Netherlands, which is looking to deepen bilateral relations with New Delhi. ASML, whose top customers include Taiwan Semiconductor Manufacturing Co (台積電) and Samsung Electronics Co, makes lithography machines that can print
PORTFOLIO REBALANCING: The adjustments in three global equity indices reflect rising investor appetite for semiconductor and artificial intelligence-related stocks Taiwan’s weighting in major global equity indices compiled by MSCI Inc is to rise modestly following the latest quarterly review, underscoring the market’s expanding role in emerging-market portfolios, as global investors continue to favor the nation’s technology sector. Taiwan’s weighting in the MSCI Emerging Markets Index is to increase by 0.30 percentage points to 23.76 percent, after the changes take effect at the close of the May 29 session. Its weighting in the MSCI All-Country Asia ex-Japan Index is to rise 0.37 percentage points to 27.16 percent, while that in the MSCI All Country World Index is to edge up slightly to
The Hsinchu County Government’s Labor Affairs Department yesterday said that it has received a plan from cosmetics brand Taiwan Shiseido Co (台灣資生堂) detailing mass layoffs at its plant in Hukou Township (湖口). While the labor authorities did not disclose the number of employees to be laid off, Japanese news media earlier in the day reported that the closure of the company’s factory in Hukou would result in 170 employees losing their jobs. Shiseido followed the law by reporting its layoff plan, the department said, adding that authorities would closely monitor negotiations between the management and affected employees and step in if any
RSS